Eli Lilly is cutting insulin prices and capping copays at $35 – 5 questions answered
- Written by Dana Goldman, Dean of the Sol Price School of Public Policy; Professor of Pharmacy, Public Policy, and Economics, University of Southern California
Diabetes management is becoming more affordable in the U.S. after years of price hikes.Matt Harbicht/Getty Images for Tandem Diabetes CarePharmaceutical giant Eli Lilly is slashing the list prices for some of its most popular insulin products by 70% and capping insulin copays at US$35 for uninsured patients and those with private health insurance....





